AI News/Wire summary
AI agent performs mouse brain injection with robotic arm in lab test
Key points
- Biotech CEO Gabriel Ocana Santero let an AI agent select a therapy and control a robotic injector on a live mouse.
- The agent chose from 19 gene therapy options; a veterinary surgeon performed the craniotomy first.
- Claude Opus 5.5 refused to guide the needle, so the team switched to Claude Sonnet 5, which proceeded.
- A coordinate glitch was fixed by a separate agent, which was not told a live surgery was underway, delaying the procedure past an hour.
Why it matters for marketers: Marketers covering AI in life sciences should note that agent-controlled lab work is being tested live, but human oversight and safeguards remain central to these claims.
Summary by the Z Media news desk, from the outlets' reporting. Read the full stories at the source.
Read the original
Wired: An AI Agent Injected Drugs Into a Live Mouse’s Brain
More coverage
Related on Z Media
- Google ships Gemini 4 Carbon and Genie 4, both in limited accessOur brief, via Google DeepMind, 5 days ago
- Mistral Large 4 released on Hugging Face with open weightsvia Hugging Face, 4 days ago
- DoorDash: outside AI agents have placed only several hundred orders so farOur brief, via TechCrunch, 2 days ago
- Amazon bets on its Ads Agent as ad revenue nears $20 billionOur brief, via Adweek, 3 days ago
- Google lets any developer submit apps for Gemini and SearchOur brief, via TechCrunch, 4 days ago
- Anthropic adds templates to Claude for Legal, with lawyer review built inOur brief, via OpenAI, 4 days ago